Menu

Top Stories

Published on Wednesday, April 20, 2016

Kevin Shroyer, father of Alpha lung donor, completes Boston Marathon

Kevin Shroyer, father of Alpha lung donor, completes Boston Marathon

Kevin Shroyer, the father of a 14-year-old girl whose donated lungs saved an Alpha’s life, completed the Boston Marathon on Monday, April 18 in her honor.

Kevin Shroyer

Although the experienced distance runner was happy to cross the finish line, he said he would like to post a faster time next year. He qualified for the event by completing a previous marathon in three hours and 35 minutes, but finished on Monday in 4:01.

"Since it was not what I was expecting to run, I will let everyone know what happened,” he wrote Monday on his Facebook page. “I was pretty much right on my pace upon climbing the infamous Heartbreak Hill. However, upon descending the back side, my right quad seized up suddenly, forcing me to come to a dead stop and grab onto a handrail to keep from falling.

“Fortunately, I was running close to the side of the road at the time. A sweet older woman spectator immediately saw the distress I was in as I could not straighten that leg out below the knee. She held onto me until the pain subsided and I was able to gradually massage it until it released, but my day was effectively over at that point.”

Calling it a “frustrating and humbling” experience, Shroyer struggled over the last six miles, alternating between fast walking and very slow running.

“This was something that had NEVER happened to me before in a race,” he wrote. “However, I accomplished goal #1 and that was to qualify, run, and finish the race for Korinne and to promote organ, tissue and eye donation on the biggest running stage in the world! It wasn't my plan to be out there for 4:01, but perhaps it was God's plan.

“Timewise, this was my worst marathon in years. But, maybe by me being out there all those additional minutes, someone was impacted by seeing Korinne's picture on the back of my singlet and the fact that she was an organ and tissue donor. Indeed, I had a number of other runners, male and female, offer expressions of condolence to me throughout the day, which was nice. So, if that is the one positive takeaway from today's experience, then I can accept that and would do it all over again!”

Shroyer has already qualified for the 2017 Boston Marathon, and he plans to run it.

“After looking at today's result they might not want me back, but too bad, I am coming!” he said. “Today will not be my defining Boston moment!"

To read about how Shroyer prepared for the Boston Marathon, click here.


Print

Emergency preparation and lung disease

Wednesday, September 12, 2018
Everyone, especially patients that require the use of oxygen or other special medical equipment, should never wait long before putting an emergency plan into practice, for emergencies, catastrophes or natural or man-made disasters. And putting...
Divider

Augmentation therapy patient-pioneer, Gerry Treichel, passes away

Wednesday, September 12, 2018
It is with a heavy heart that the Alpha-1 Foundation announces the passing of Gerald (Gerry) Treichel, beloved member of the Alpha-1 community for many years and one of the pioneer patients for augmentation therapy, in the evening of Sunday,...
Divider

A good age: Denied a lung transplant, she keeps on trekking

Tuesday, September 11, 2018
In her determination, Alyce Yout has a compelling courage and buoyancy. After living with lung disease for 26 years, the former pediatric nurse had high hopes for a lung transplant last fall. “We began the journey to a transplant after...
Divider

Sharp drop in portable oxygen access blamed on provider pay changes

Monday, September 10, 2018
A coalition of pulmonary health groups called on the Centers for Medicare & Medicaid Services (CMS) to change its supplemental oxygen reimbursement policy to remove liquid oxygen from competitive bidding requirements. The American Lung...
Divider

New advances in gene therapies for rare diseases

Friday, August 31, 2018
The U.S. Food and Drug Administration (FDA) recently approved Onpattro (patisiran) infusion for the treatment of peripheral nerve disease (polyneuropathy) caused by hereditary transthyretin-mediated amyloidosis (hATTR) in adult patients. This...
Divider

Alpha-1 Foundation leadership transition

Wednesday, August 22, 2018
The Alpha-1 Foundation Board of Directors is pleased to announce that Miriam O’Day has been named as interim CEO of the Alpha-1 Foundation. Ms. O’Day has served the Foundation with distinction for nearly twenty years. The Board is...
Divider

Alpha-1 Foundation earns 8th consecutive 4-star rating from Charity Navigator

Wednesday, August 22, 2018
The Alpha-1 Foundation has earned its eighth consecutive 4-star rating from Charity Navigator, an accomplishment that only select charities achieve in the U.S. The Foundation earned its top score based on Charity Navigator’s evaluation of...
Divider

Orphan Drug Designation granted to Bronchiolitis Obliterans treatment

Friday, August 17, 2018
Onspira Therapeutics announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation to its investigational product, OSP-101, for the treatment of Bronchiolitis Obliterans (BO). BO is a progressive inflammatory condition...
Divider

Family of liver donor meets transplant recipient

Friday, August 10, 2018
On June 19, Cletus Schnieders was eating dinner with his wife Carrie and their three children (sons Trenton, 9, and Cletie, 4, and daughter Samantha, 2) in their Cincinnati home when he started to choke. Photo: Facebook/Carrie...
Divider

Living donor saved her own son’s life

Tuesday, July 31, 2018
Dara Kass is an emergency physician in New York, but she did not need to be a doctor to know that something was going on with the third child, Sammy. At birth, the baby was smaller than his two siblings. He barely grew and was lethargic; his skin...
Divider

The Assistance Fund opens new program for Alphas

Monday, July 30, 2018
The Assistance Fund, an independent charitable patient assistance foundation that helps patients and families facing high medical out-of-pocket costs, announced the launch of a new program for individuals with Alpha-1 Antitrypsin Deficiency...
Divider

Alpha-1 Foundation board has new Chair

Friday, July 27, 2018
The Alpha-1 Foundation has the honor to announce that Jeanine D’Armiento, MD, PhD, has been named as the newest Chair of its board of directors. D’Armiento has served on the Foundation’s board since 2011, and before that, she had...
Divider
12345678910Last

Article Search

Enter keywords in text box and click Search button for results.

Archive